Interleukin 6 Receptor Antagonists [MoA] - N0000190478

  1. Home
  2. Pharmacologic Class Index
  3. Interleukin 6 Receptor Antagonists [MoA] - N0000190478

Pharmacologic Class Information

Pharmacologic Code N0000190478
Pharmacologic Name Interleukin 6 Receptor Antagonists
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Interleukin 6 Receptor Antagonists

The table contains 9 products whose active ingredient are classified under the same pharmacologic class Interleukin 6 Receptor Antagonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0024-5908Kevzara Non-Proprietary Name: SarilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcACTIVE
0024-5910Kevzara Non-Proprietary Name: SarilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcACTIVE
0024-5920Kevzara Non-Proprietary Name: SarilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcACTIVE
0024-5922Kevzara Non-Proprietary Name: SarilumabInjection, SolutionSubcutaneousSanofi-aventis U.s. LlcACTIVE
50242-135Actemra Non-Proprietary Name: TocilizumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-136Actemra Non-Proprietary Name: TocilizumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-137Actemra Non-Proprietary Name: TocilizumabInjection, Solution, ConcentrateIntravenousGenentech, Inc.ACTIVE
50242-138Actemra Non-Proprietary Name: TocilizumabInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE
50242-143Actemra Actpen Non-Proprietary Name: TocilizumabInjection, SolutionSubcutaneousGenentech, Inc.ACTIVE